Autopsy report · NCT02681419

Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period

“Investigator left institution”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 1 month after it had already started.
• Ran for about 4 years 2 months before it stopped.
• 18 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

The University of Texas Health Science Center, Houston

Sponsor type

University, hospital or other

Conditions

Glaucoma

Interventions

Needle fenestration; Suture wick

Participants

18

Sites

1

Countries

United States

Trials that died the same way

• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (96% match in meaning)
• Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection
  “Primary investigator left institution” (94% match in meaning)
• Prepectoral vs Partial Subpectoral Two-Stage Implant-Based Breast Reconstruction
  “Principal Investigator left institution” (93% match in meaning)
• Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee Arthroplasty
  “Responsible Investigator left institution” (93% match in meaning)
• Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations
  “Investigator departed from institution” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.